SCHOTT Pharma AG & Co. KGaA (1SXP) - Cash Flow Conversion Efficiency

Latest as of September 2024: 0.096x

Based on the latest financial reports, SCHOTT Pharma AG & Co. KGaA (1SXP) has a cash flow conversion efficiency ratio of 0.096x as of September 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€75.97 Million ≈ $88.82 Million USD) by net assets (€792.27 Million ≈ $926.25 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See SCHOTT Pharma AG & Co. KGaA (1SXP) balance sheet quality index to measure how much of total assets are equity-financed.

SCHOTT Pharma AG & Co. KGaA - Cash Flow Conversion Efficiency Trend (2020–2024)

This chart illustrates how SCHOTT Pharma AG & Co. KGaA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check SCHOTT Pharma AG & Co. KGaA earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.

SCHOTT Pharma AG & Co. KGaA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of SCHOTT Pharma AG & Co. KGaA ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Proximus NV BR:PROX	0.076x
Coface SA PA:COFA	0.013x
Aehr Test Systems NASDAQ:AEHR	-0.021x
Tonghua Golden-Horse Pharmaceutical Industry Co Ltd SHE:000766	-0.003x
China Longyuan Power Group Corporation Limited F:6WX	-0.022x
Hamilton Insurance Group, Ltd. NYSE:HG	0.037x
Boise Cascad Llc NYSE:BCC	-0.008x
Diamondrock Hospitality Company Common Stock NASDAQ:DRH	0.015x

Annual Cash Flow Conversion Efficiency for SCHOTT Pharma AG & Co. KGaA (2020–2024)

The table below shows the annual cash flow conversion efficiency of SCHOTT Pharma AG & Co. KGaA from 2020 to 2024. For the full company profile with market capitalisation and key ratios, see 1SXP company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-06-30	€792.27 Million ≈ $926.25 Million	€225.33 Million ≈ $263.43 Million	0.284x	+8.37%
2023-06-30	€692.18 Million ≈ $809.23 Million	€181.65 Million ≈ $212.37 Million	0.262x	+2.17%
2022-06-30	€709.04 Million ≈ $828.95 Million	€182.12 Million ≈ $212.92 Million	0.257x	-18.52%
2021-06-30	€419.42 Million ≈ $490.34 Million	€132.21 Million ≈ $154.57 Million	0.315x	-4.69%
2020-06-30	€315.66 Million ≈ $369.04 Million	€104.40 Million ≈ $122.05 Million	0.331x	--

About SCHOTT Pharma AG & Co. KGaA

XETRA:1SXP Germany Medical Instruments & Supplies

Market Cap

$3.87 Billion

€3.31 Billion EUR

Market Cap Rank

#5500 Global

#874 in Germany

Share Price

€21.95

Change (1 day)

-0.23%

52-Week Range

€12.96 - €24.60

All Time High

€41.20